Jump to main content
Jump to site search

Issue 10, 2012
Previous Article Next Article

Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells

Author affiliations

Abstract

Small molecule ruthenium complexes show great promise as anticancer pharmaceuticals, but further rational development of these as drugs is stymied by an incomplete understanding of the mechanisms that give rise to markedly different biological behaviour for structurally similar species. X-ray fluorescence imaging at two incident energies was used to reveal the intracellular distribution of Ru in single human cells treated with KP1019, showing Ru localised in both cytosol and in the nuclear region. In addition the imaging showed that treatment with KP1019 modulated Fe distribution to resemble the Ru distribution, without affecting cellular Fe content. In stark contrast, Ru could not be visualised in cells treated with NAMI-A, indicating that it was not internalised and supporting the proposition that its activity is exerted through a membrane-binding mechanism.

Graphical abstract: Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells

Back to tab navigation

Supplementary files

Publication details

The article was received on 23 Apr 2012, accepted on 06 Aug 2012 and first published on 08 Aug 2012


Article type: Paper
DOI: 10.1039/C2MT20072D
Citation: Metallomics, 2012,4, 1051-1056

  •   Request permissions

    Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells

    J. B. Aitken, S. Antony, C. M. Weekley, B. Lai, L. Spiccia and H. H. Harris, Metallomics, 2012, 4, 1051
    DOI: 10.1039/C2MT20072D

Search articles by author

Spotlight

Advertisements